Objective: Patients with supracoronary ascending aortic aneurysms can have aortic insufficiency (AI) due to dilatation of the sinotubular junction and/or associated cusp pathology. The incidence and types of cusp lesions as well as the effect of AI severity and cusp repair techniques on outcome in this patient population is not well defined. Methods: Since 1996, 55 patients (mean age: 65 AE 13 years, 17 bicuspid valves) presented with supracoronary ascending aortic aneurysms and AI that was mild/moderate in 27 (49%) and severe in 28 (51%). Associated pathology included cusp prolapse in 18 (33%), cusp restriction in nine (16%) and both in three (5%). All patients underwent aortic replacement and remodeling of the sinotubular junction. Adjunctive techniques included subcommissural annuloplasty in 38(69%) and cusp repair in 28 (51%). Results: AI severity was not significantly associated with the presence of cusp pathology ( p = 0.35). Cusp disease was present in 100% of bicuspid aortic valves compared with only 34% of trileaflet valves ( p < 0.001). There was no hospital mortality and overall survival was 94 AE 4% and 75 AE 10%, respectively, at 5 and 7 years. Freedom from re-operation was 100% at 7 years and freedom from recurrent AI (>2+) was 87 AE 7% at 5 years. Neither the presence of preoperative severe AI, nor the need for cusp repair was predictive of late outcome. Conclusions: Cusp pathology is frequently encountered in patients with ascending aortic dilatation and AI. Severe AI is not a contraindication to valve-preserving surgery, but careful identification and repair of cusp pathology, in addition to sinotubular junction reduction, is critical for durable, long-term outcome. #
Introduction
The aortic valve (AV) annulus is a three-dimensional structure, which includes the sinotubular junction (STJ), the ventriculo-aortic junction, and the crown-shaped 'anatomic' annulus, which serves as the base of cusp insertion [1] . These three structures comprise the 'functional aortic annulus' and play a critical role in the normal functioning of the AV. In particular, dilatation of the STJ is an important cause of aortic insufficiency (AI).
Although the repair of a supracoronary ascending aneurysm is not a technically demanding procedure, alteration or distortion of the STJ can induce AV incompetence, and remodeling of the STJ can unmask previously undiagnosed cusp prolapse. While patients with supracoronary ascending aortic dilatation can have AI due to dilatation of the STJ [2] , AI in this setting may also be due to coexisting cusp disease.
The nature of cusp pathology associated with supracoronary ascending aortic aneurysms has not been well characterized.
In this study, we sought to evaluate our single-center experience with the treatment of patients, who presented with ascending aortic aneurysm and coexisting AI, and underwent aortic replacement with or without cusp repair. Specifically, the objective was to describe the associated cusp pathology encountered, to evaluate mid-to long-term outcomes, and to determine whether preoperative, severe AI was a risk factor for poor outcome.
Patients and methods

Patient population
This study was approved by the Institutional Research Ethics Committee at Cliniques Saint Luc, Brussels, Belgium where all study patients were treated, and written informed consent was waived for this study. Between 1996 and 2008, 55 patients presented non-emergently with supracoronary ascending aortic aneurysm and varying degrees of AI. All patients were classified according to our previously published repair-oriented classification of AI [3] , in which dilatation of the functional aortic annulus (comprising of the STJ and the ventriculo-aortic junction) are classified as type 1. Specifically, patients with supracoronary ascending aortic aneurysms have dilatation of the STJ and are subclassified as type 1a. Mean age of this cohort was 60 AE 17 years, and 71% were male. Patient preoperative characteristics are presented in Table 1 . The number of cases performed per year is depicted in Fig. 1 . Early in our experience, as we went through the learning curve for AV repair, there was a low threshold for replacing the valve. However, with increasing experience, we have applied this strategy of valve-sparing aortic replacement in larger numbers. In the last 2-3 years, our surgical strategy has evolved further toward more aggressive root replacement, particularly in patients with bicuspid aortic valves with the goal of providing a more durable repair, which is reflected in the reduced number of patients undergoing valve-preserving supracoronary aortic replacement.
Surgical techniques
All patients underwent supracoronary ascending aortic replacement and STJ remodeling with a Dacron prosthesis. The operative technique has been previously described [4] . Briefly, the aortic arch (or the axillary/femoral artery in the case of aortic arch involvement) was cannulated and a single two-stage cannula was inserted through the right atrial appendage. Following the application of the aortic crossclamp, antegrade blood cardioplegia was administered through the aortic root or directly through the coronary ostia in the setting of severe AI. The aorta was transected approximately 1 cm above the STJ, commissural suspension sutures were applied and the aortic valve was examined.
Functional aortic annulus
The STJ was remodeled in all patients. First, axial traction was applied to the commissural suspension sutures to determine the size of the STJ that provided optimal leaflet co-aptation. A Hegar dilator or a Freestyle stentless valve sizer (Medtronic Inc., Minneapolis, MN, USA) was then used to estimate the diameter of the STJ that resulted in good cusp co-aptation. A woven Dacron prosthesis of that diameter was used (Gelweave TM Vascutek; Renfrewshire, Scotland), and the prosthesis was first anchored at the three commissures (two in the case of a bicuspid valve) to ensure equal spacing. In patients with significant preoperative AI or dilated interleaflet triangles, subcommissural annuloplasty was performed using 2/0 braided sutures reinforced with pledgets. This maneuver was performed to reduce the diameter of the aorto-ventricular junction and protect against further dilatation as well as to improve cusp coaptation.
Cusp repair
In trileaflet valves, cusp prolapse was corrected using either central free-margin plication, free-margin resuspension using polytetrafluoroethylene (PTFE), or both, as previously described [4] . The management of cusp disease in bicuspid AVs depended on the valve morphology and the quality of the raphe. If the raphe was fibrous, without significant calcification, it was simply shaved and the leaflet was left intact. If the raphe was calcified or severely restrictive, it was resected. Next, if there was adequate residual cusp tissue, a primary reapproximation was performed. In the setting of inadequate cusp tissue, a pericardial patch (either bovine pericardium or gluteraldehyde-treated autologous pericardium) was used for cusp restoration. Following this, the two cusps were compared for the presence of any prolapse, which was corrected by freemargin plication, free-margin resuspension or both. Intraoperative data are described in Table 2 .
Prior to performance of the distal aortic anastomosis, a dose of cardioplegia was administered through the Dacron tube graft. In addition to assessing hemostasis, a limited echocardiographic view of the AV and left-ventricular outflow tract was often obtainable during this time to assess for major residual AI. After cardioplegia delivery, the remaining solution was gently aspirated from the aortic root and the leaflets were examined for the height of co-aptation. The goal was to have a co-aptation level approximately at the mid-height of the sinuses of Valsalva.
Follow-up
Clinical follow-up was conducted either through outpatient visits or telephone follow-up by a research nurse. Information on survival status, valve-related complications including thrombo-embolism, hemorrhage, endocarditis, re- 
Statistical analysis
Valve-related outcomes were defined as per published guidelines [5] . Continuous data are presented as mean AE standard deviation. Group comparisons for categorical data were performed using the chi-squared test or Fisher's exact test if the cell count was less than 5. Failure time data on survival, re-operation and recurrent AI are presented using Kaplan-Meier survival curves. Actual rates for nonfatal events were also calculated. Comparisons between groups for failure-time data were performed using the logrank test. Statistical analyses were performed using SAS v. 9.1 (SAS Institute, Cary, NC, USA). Graphs were constructed using GraphPad Prism 5.0 (San Diego, CA, USA).
Results
Pathology and techniques
AVs were bicuspid in 17 patients (31%) and tricuspid in 38 (69%). Severity of preoperative AI was not associated with the presence of cusp disease ( p = 0.35). Cusp repair was performed in 51% of the cohort and was required in 100% of patients with bicuspid AVs compared with only 29% with tricuspid AVs ( p < 0.001). Cusp pathology in tricuspid AVs always involved prolapse of one or more cusps. In bicuspid AVs, cusp pathology involved cusp restriction in seven (41%), cusp prolapse in seven (41%) and both in three (18%). Cusprepair techniques are described in Table 2 .
Early outcome
There was no early mortality or AV re-operation. Four patients required reexploration for postoperative hemorrhage, one patient required a permanent pacemaker, and two patients had postoperative stroke. Pre-discharge echocardiography showed AI grade 0 or 1 in 93% and AI grade 2 in 7%. One patient had an AV gradient greater than 25 mmHg.
Late outcome
Six patients died during follow-up. The cause of death was non-cardiac in four patients, cardiac in one patient and unknown in one (this patient was counted as a valve-related death). Overall survival was 94 AE 4% at 5 years and 75 AE 10% and 7 years (Fig. 2) . One patient underwent an AV replacement for progressive aortic valve stenosis 8 years after the initial procedure. Two other patients underwent non-AV re-operations, one for descending thoracic aortic aneurysm and another for replacement of a pulmonary homograft in a patient, who previously had a Ross procedure. Overall actuarial freedom from AV re-operation was 100% at 7 years. Other valve-related events included one patient treated medically for endocarditis and a perioperative stroke in the patient, who underwent descending thoracic aortic replacement from which he recovered fully. Overall actuarial freedom from all valve-related events (including cardiac death, AV re-operation, thrombo-embolism, bleeding or endocarditis) was 94 AE 5% (95% confidence interval (CI): 77%-98%) at 5 years and 87 AE 8% (95% CI: 61-96%) at 7 years (linearized rate of 1.6% per patient year). Echocardiographic follow-up revealed that actuarial freedom from AI > 2+ was 97 AE 3% (95% CI: 80-99%) at 3 years and 87 AE 7% (95% CI: 64-96%) at 5 years. Actual freedom from recurrent AI > 2+ was 98% at 3 years and 95% at 5 years. Of the remaining patients, 10 had grade II AI, 25 had grade I AI, and 12 had no AI. None of the patients with mild-to-moderate AI had evidence of leftventricular dilatation (left-ventricular end-diastolic diameter < 60 mm in all patients). Of the four patients with recurrent AI, three had bicuspid AVs and all underwent subcommissural annuloplasty. One had presented with endocarditis, which required resection of a vegetation and coverage with a pericardial patch. The other two bicuspid valve patients underwent triangular resection of the raphe with primary reapproximation, with one undergoing additional correction of cusp prolapse using free-margin resuspension. The fourth patient had a trileaflet AV and, in addition to subcommissural annuloplasty and ascending aortic replacement, underwent free-margin plication of a prolapsing left coronary cusp. We examined the effect of preoperative AI and of need for cusp repair on the composite end point of cardiac death and recurrent AI (Fig. 3) . We found that freedom from cardiac death or recurrent AI was similar in patients with or without preoperative severe AI ( p = 0.23), and in those who did or did not undergo cusp prolapse repair ( p = 0.79).
Discussion
In this single-center series, we demonstrate that valvepreserving surgery in the setting of supracoronary ascending aortic aneurysms and AI is feasible and yields good, longterm, event-free survival, freedom from recurrent AI and freedom from AV re-operation. Cusp pathology is encountered in approximately half of the patient population and is not associated with the severity of preoperative AI. Patients with a bicuspid valve are significantly more likely to require cusp intervention. Importantly, the presence of preoperative severe AI or the need for cusp repair is not risk factors for poor, long-term outcome.
Supracoronary ascending aortic aneurysms are an infrequent cause of AI, accounting for approximately 15% of patients undergoing AV repair. The conventional treatment for patients who present with supracoronary ascending aortic aneurysms and AI involves replacement of the AV with a mechanical or biologic prosthesis and replacement of the ascending aorta with a Dacron tube graft [6] . Advances in the understanding of the mechanisms of AI in this setting has led to the development of AV-preserving surgery. However, unlike AV-sparing root replacement [7, 8] , this patient population has received less attention in the literature. The first important observation from this study is that cusp pathology is frequently encountered and may either be evident on preoperative echocardiography or be unmasked during surgery. A careful and thorough examination of the AV is therefore an essential component of the procedure. Our approach for valve assessment is to apply axial traction on the commissural sutures placed at each commissure and examine absolute cusp height and free-margin length, as well as relative to the other cusps [4] .
Management of cusp pathology can be quite different in bicuspid versus tricuspid AVs. In association with ascending aortic aneurysms, tricuspid AVs almost invariably have cusp prolapse as the concomitant pathology. This can be corrected by free-margin plication or free-margin resuspension, as previously described [4] . By contrast, bicuspid valve anatomy can be quite variable. Our approach to bicuspid AV repair has been previously described [9] , and builds on a previously published classification of bicuspid valve anatomy [10] . In a symmetric bicuspid valve (Type 0), cusp prolapse is typically the mechanism of insufficiency and can be corrected as described for tricuspid AVs. In asymmetric (Type 1) bicuspid valves, management of the raphe is a key component of cusp repair. The raphe can either be shaved and preserved if tissue quality is good or be resected if it is calcified or severely restrictive. If resected, the defect may be directly reapproximated or a pericardial patch may be used for cusp restoration. In the context of supracoronary ascending aneurysm repair, our rate of cusp intervention is higher than the 28% reported by David et al. [11] , likely because of the larger proportion of bicuspid AVs included in our series (31% vs 9%).
Another issue that remains controversial in the setting of bicuspid AV disease and ascending aortic aneurysm is the threshold for root replacement. Schafers et al. have shown a high risk of re-operation (47% at 5 years) in patients, who underwent bicuspid AV repair with supracoronary ascending aortic replacement compared with those who underwent concomitant root remodeling [12] . Morimoto et al. also found that a bicuspid AV was a risk factor for failure following ascending aortic replacement [13] . In our experience with bicuspid AV repair, root replacement was also protective against recurrent AI [9] . This may be due to progressive dilatation of the ventriculo-aortic junction and the aortic root in these patients, who have been demonstrated to show abnormal AV tissue at the microscopic level. As such, our threshold for aortic root replacement in patients is now quite low.
An important adjunctive technique that can help to stabilize the ventriculo-aortic junction in these patients is the addition of subcommissural annuloplasty sutures. Our current approach involves adding subcommissural annuloplasty sutures in all patients with significant preoperative AI ($70% in this series). In addition to reducing the size of the ventriculo-aortic junction, this maneuver can also increase cusp co-aptation surface. Ultimately, the most effective method for stabilizing the AV annulus is through valve-sparing root replacement using the reimplantation technique.
Examination of the demographic characteristics of this population highlights important differences compared with patients presenting with primary aortic root disease and other patients undergoing AV repair. Patients with supracoronary ascending aortic dilation are typically older (mean age 60 years), have a higher burden of atherosclerosis and other aneurysmal disease and are more likely to undergo concomitant cardiac procedures (45% in this series). This is similar to data reported by David et al. and others [11, 13] . As such, overall survival is lower compared with patients undergoing valve-sparing root replacement, largely due to non-cardiac death. The benefits of AV repair, however, persist even in this older cohort with a combined linearized risk of all valve-related morbidity of 1.6% per patient year. By contrast, structural valve deterioration (SVD) following bioprosthetic AV replacement in this age group is estimated at a linearized rate of 2-3% year À1 [14] and the additional linearized risk of thrombo-embolic complications is between 1 and 2% year À1 [15] . The benefits would also be evident in those patients, who would otherwise undergo mechanical AV replacement, who have a lower risk of SVD but who carry the additional burden of anticoagulation-related hemorrhage. Ultimately, the decision to perform a repair versus replacement is dependent on several patient-related and valve-related factors and, most importantly, on patient choice.
Study limitations
This is a single-center series in which surgical techniques have evolved over the past 13 years. Echocardiograms not performed at our institution were interpreted by the referring cardiologist and did not always contain detailed and quantitative information about the degree of AI and its mechanisms. A closer study of follow-up echocardiograms may give important insights into the mechanisms for recurrent AI. Lastly, late echocardiographic follow-up was not available in five patients and the risk of recurrent AI may be underestimated.
Conclusions
Patients with supracoronary ascending aortic aneurysms and AI frequently have concomitant cusp pathology, particularly in bicuspid AVs. This pathology should be identified and corrected at the time of repair. AV preservation, and repair in this setting is associated with good, long-term outcome and a low incidence of valve-related events. Severe preoperative AI or need for cusp repair should not be considered a contraindication for AV preservation.
